Is a Leiomyoma Diagnosis on My Pathology Report Cause for Concern?

Pathology reports diagnosing uterine leiomyomas—commonly known as fibroids—are generally not a cause for concern. Leiomyomas are benign smooth muscle tumors of the uterus, representing the most frequent solid pelvic neoplasms in individuals assigned female at birth. They occur in up to 70–80% of this population by age 50, with prevalence varying by race, genetics, and hormonal exposure.

While leiomyomas are almost always nonmalignant, pathologists carefully evaluate tissue specimens for features that may suggest atypical or malignant transformation—such as marked nuclear pleomorphism, high mitotic activity (≥10 mitoses per 10 high-power fields), and tumor cell necrosis. In rare cases (<0.1%), a diagnosis of leiomyosarcoma—a highly aggressive sarcoma—may be rendered, but this is histologically and clinically distinct from typical leiomyomas and does not arise from them in most instances.

A routine pathology report confirming a classic leiomyoma indicates no evidence of malignancy, and management is typically conservative unless symptoms—such as menorrhagia, pelvic pressure, bulk-related discomfort, or infertility—are present. Surveillance, medical therapy, or procedural interventions (e.g., myomectomy, uterine artery embolization, or hysterectomy) are guided by symptom burden, reproductive goals, and imaging correlation—not by the mere presence of the diagnosis itself.

Patients should discuss their pathology findings with a gynecologist or gynecologic oncologist to contextualize results within their clinical picture, especially if atypical histologic features were noted or if rapid growth was observed preoperatively.